Lebiran

Lebiran is a Lebanese pharmaceutical company founded in 2014, specializing in the import, export, and trade of high-tech biosimilar products. The company focuses on therapeutic areas such as oncology, immunology, infertility, and hormone disorders, providing treatments for rare and chronic diseases. Lebiran partners with leading regional biotechnology firms, notably CinnaGen and Nano Alvand, to supply the Lebanese market with biosimilar versions of major biologics like Rituximab, Etanercept, and Bevacizumab. Despite facing legal and political scrutiny regarding its registration and the origin of its products, the company remains an active distributor of specialized medicines in Lebanon. Its portfolio includes a range of monoclonal antibodies, fusion proteins, and small molecules aimed at improving patient access to cost-effective treatments.